Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases
FJM Marón, AB Camargo, W Manucha - Life sciences, 2020 - Elsevier
… clarify the common molecular mechanisms by which allicin and its derivates molecules may
perform its therapeutic effects on cardiovascular diseases and neuroinflammatory processes…
perform its therapeutic effects on cardiovascular diseases and neuroinflammatory processes…
Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
Y Shi, H Zhang, S Huang, L Yin, F Wang… - … and Targeted Therapy, 2022 - nature.com
… diagnosis and treatment of cardiovascular diseases. Herein, … essential regulatory mechanisms
in cardiovascular diseases. … are important molecular markers of cardiovascular disease …
in cardiovascular diseases. … are important molecular markers of cardiovascular disease …
Aging: molecular pathways and implications on the cardiovascular system
AJPO Almeida, TP Ribeiro… - Oxidative medicine and …, 2017 - Wiley Online Library
… mechanisms that lead to aging drive towards age-related diseases, in particular, the
cardiovascular diseases, … age-related diseases, in particular, the cardiovascular diseases, the …
cardiovascular diseases, … age-related diseases, in particular, the cardiovascular diseases, the …
Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies
… of cardiovascular, metabolic, and emerging infectious diseases. Pharmacotherapies
targeting … dysfunction have potential for treatment of cardiovascular and many other diseases. …
targeting … dysfunction have potential for treatment of cardiovascular and many other diseases. …
microRNAs in cardiovascular disease: small molecules but big roles
B Yan, H Wang, Y Tan, W Fu - Current topics in medicinal …, 2019 - ingentaconnect.com
… mechanisms and therapeutic trials of several representative miRNAs in the context of specific
cardiovascular diseases… of miRNA-based chemical molecules and consider the underlying …
cardiovascular diseases… of miRNA-based chemical molecules and consider the underlying …
The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: a review of the molecular mechanisms
JN Chun, M Cho, I So, JH Jeon - Fitoterapia, 2014 - Elsevier
… on cardiovascular disease have important translational implications [10]. Scientific investigations
of the molecular mechanisms … and its lignans exert cardiovascular protective activity by …
of the molecular mechanisms … and its lignans exert cardiovascular protective activity by …
Autophagy as a therapeutic target in cardiovascular disease
A Nemchenko, M Chiong, A Turer, S Lavandero… - Journal of molecular and …, 2011 - Elsevier
… of cardiovascular disease. We discuss ways in which this evolutionarily conserved catabolic
mechanism can be manipulated, discuss studies presently underway in heart disease, and …
mechanism can be manipulated, discuss studies presently underway in heart disease, and …
Cardiac aging: from molecular mechanisms to significance in human health and disease
… Cardiovascular diseases (CVDs) are the major causes of death in the western world. The
incidence of cardiovascular disease as well as the rate of cardiovascular mortality and …
incidence of cardiovascular disease as well as the rate of cardiovascular mortality and …
HDL-mediated mechanisms of protection in cardiovascular disease
A Kontush - Cardiovascular research, 2014 - academic.oup.com
… a strong and independent risk factor for cardiovascular disease. HDL particles display a wide
… Together with clear understanding of molecular mechanisms underlying atheroprotective …
… Together with clear understanding of molecular mechanisms underlying atheroprotective …
The molecular basis of predicting atherosclerotic cardiovascular disease risk
M Nayor, KJ Brown, RS Vasan - Circulation research, 2021 - Am Heart Assoc
… each phase of atherosclerotic cardiovascular disease development can be captured. …
cardiovascular disease risk in humans using peripheral blood molecular signatures and molecular …
cardiovascular disease risk in humans using peripheral blood molecular signatures and molecular …